These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12384886)

  • 21. Complications of the hypercoagulable status in burn injury.
    Barret JP; Dziewulski PG
    Burns; 2006 Dec; 32(8):1005-8. PubMed ID: 16879922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of venous thromboembolism.
    Pini M; Spyropoulos AC
    Semin Thromb Hemost; 2006 Nov; 32(8):755-66. PubMed ID: 17171588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of venous thromboembolism.
    Kearon C
    Circulation; 2003 Jun; 107(23 Suppl 1):I22-30. PubMed ID: 12814982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venous thromboembolism prophylaxis in medical patients: future perspectives.
    Imberti D; Prisco D
    Thromb Res; 2005; 116(5):365-75. PubMed ID: 16122549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extensive cerebral venous thrombosis in a renal allograft recipient.
    Nayak SG; Satish R;
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):90-3. PubMed ID: 18087132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery.
    Epstein NE
    Surg Neurol; 2005 Oct; 64(4):295-301; discussion 302. PubMed ID: 16181995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary embolism at autopsy in a normal population: implications for air travel fatalities.
    Pheby DF; Codling BW
    Aviat Space Environ Med; 2002 Dec; 73(12):1208-14. PubMed ID: 12498550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Conclusions of consensus development conferences on the prevention and treatment of venous thromboembolism].
    István L; Rák K; Losonczy H; Blaskó G
    Orv Hetil; 2003 Jul; 144(29):1427-31. PubMed ID: 12939863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Travel, venous thromboembolism, and thrombophilia.
    Gallus AS
    Semin Thromb Hemost; 2005 Feb; 31(1):90-6. PubMed ID: 15706480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
    Turpie AG; Bauer KA; Davidson BL; Fisher WD; Gent M; Huo MH; Sinha U; Gretler DD;
    Thromb Haemost; 2009 Jan; 101(1):68-76. PubMed ID: 19132191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can thromboembolism be the result, rather than the inciting cause, of acute vascular events such as stroke, pulmonary embolism, mesenteric ischemia, and venous thrombosis?: a maladaptation of the prehistoric trauma response.
    Yun AJ; Lee PY; Bazar KA
    Med Hypotheses; 2005; 64(4):706-16. PubMed ID: 15694686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction to thrombosis proficient and cost-effective approaches to thrombosis.
    Bick RL
    Hematol Oncol Clin North Am; 2003 Feb; 17(1):1-8, v. PubMed ID: 12627660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinically overt venous thromboembolism after urologic cancer surgery: results from the @RISTOS Study.
    Scarpa RM; Carrieri G; Gussoni G; Tubaro A; Conti G; Pagliarulo V; Mirone V; De Lisa A; Fiaccavento G; Cormio L; Bonizzoni E; Agnelli G;
    Eur Urol; 2007 Jan; 51(1):130-5; discussion 136. PubMed ID: 16942832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous thromboembolism: pathophysiology and clinical presentation.
    Haines ST
    Am J Health Syst Pharm; 2003 Nov; 60(22 Suppl 7):S3-5. PubMed ID: 14650859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Action to reduce incidence of venous thromboembolism.
    Hainsworth T
    Nurs Times; 2005 Aug 16-22; 101(33):26-7. PubMed ID: 16130495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboembolic phenomena.
    Caswell DR
    Crit Care Nurs Clin North Am; 1993 Sep; 5(3):489-97. PubMed ID: 8217044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dyslipidemia, statins, and venous thromboembolism: a potential risk factor and a potential treatment.
    Ray JG
    Curr Opin Pulm Med; 2003 Sep; 9(5):378-84. PubMed ID: 12904707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inherited risk factors for venous thromboembolism: implications for clinical practice.
    Ridker PM
    Clin Cornerstone; 2000; 2(4):1-14. PubMed ID: 10800660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Practical aspects concerning the use of anticoagulants in urology].
    Coloby P; Zufferey P
    Ann Urol (Paris); 2006 Nov; 40 Suppl 3():S94-101. PubMed ID: 17366864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.